Phosphorylation of enteroviral 2A pro at Ser/Thr125 benefits its proteolytic activity and viral pathogenesis
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Yuya Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. Hauptthemen laut MEDLINE: Enterovirus A, Human, Enterovirus Infections, Viral Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Enteroviral 2A proteinase (2A pro ), a well‐established and important viral functional protein, plays a key role in shutting down cellular cap‐dependent translation, mainly via its proteolytic activity, and creating optimal conditions for Enterovirus survival. Accumulated data show that viruses take advantage of various signaling cascades for their life cycle; studies performed by us and others have demonstrated that the extracellular signal‐regulated kinase (ERK) pathway is essential for enterovirus A71 (EV‐A71) and other viruses replication. We recently showed that ERK1/2 is required for the proteolytic activity of viral 2A pro ; however, the mechanism underlying the regulation of 2A pro remains unknown. Here, we demonstrated that the 125th residue Ser125 of EV‐A71 2A pro or Thr125 of coxsackievirus B3 2A pro , which is highly conserved in the Enterovirus , was phosphorylated by ERK1/2. Importantly, 2A pro with phosphor‐Ser/Thr125 had much stronger proteolytic activity toward eukaryotic initiation factor 4GI and rendered the virus more efficient for multiplication and pathogenesis in hSCARB2 knock‐in mice than that in nonphospho‐Ser/Thr125A (S/T125A) mutants. Notably, phosphorylation‐mimic mutations caused deleterious changes in 2A pro catalytic function (S/T125D/E) and in viral propagation (S125D). Crystal structure simulation analysis showed that Ser125 phosphorylation in EV‐A71 2A pro enabled catalytic Cys to adopt an optimal conformation in the catalytic triad His‐Asp‐Cys, which enhances 2A pro proteolysis. Therefore, we are the first to report Ser/Thr125 phosphorylation of 2A pro increases enteroviral adaptation to the host to ensure enteroviral multiplication, causing pathogenicity. Additionally, weakened viruses containing a S/T125A mutation could be a general strategy to develop attenuated Enterovirus vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
- Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
- Jiangxi Provincial Key Laboratory of Tumor Pathogens and Molecular Pathology, Queen Mary School, Nanchang University Jiangxi Medical College, Nanchang, China.
- Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, China.
- Department of Microbiology, Harbin Medical University, Harbin, China.
Zitieren
APA
Wang, Y., Zou, W., Niu, Y., Wang, S., Chen, B., Xiong, R., Zhang, P., Luo, Z., Wu, Y., Fan, C., Zhong, Z., Xu, P., & Peng, Y. (2023). Phosphorylation of enteroviral 2A pro at Ser/Thr125 benefits its proteolytic activity and viral pathogenesis. Journal of Medical Virology. https://doi.org/10.1002/jmv.28400
Vancouver
Wang Y, Zou W, Niu Y, Wang S, Chen B, Xiong R, et al. Phosphorylation of enteroviral 2A pro at Ser/Thr125 benefits its proteolytic activity and viral pathogenesis. Journal of Medical Virology. 2023. doi:10.1002/jmv.28400
BibTeX
@article{Wang2023,
author = {Wang, Yuya and Zou, Wenjia and Niu, Yan and Wang, Sanyuan and Chen, Bangtao and Xiong, Rui and Zhang, Peng and Luo, Zhijun and Wu, Yong and Fan, Changfa and Zhong, Zhaohua and Xu, Ping and Peng, Yihong},
title = {Phosphorylation of enteroviral 2A pro at Ser/Thr125 benefits its proteolytic activity and viral pathogenesis},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28400}
}
EUVIMED